- Conditions
- Barotrauma;Ear, OME - Otitis Media With Effusion, AOM - Acute Otitis Media, Eustachian Tube Dysfunction
- Interventions
- Tymbion Iontophoresis and Tube Delivery System (TDS)
- Combination Product
- Lead sponsor
- Tusker Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 8
- States / cities
- Roseville, California • San Jose, California • Louisville, Kentucky + 5 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 24
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Otitis Media Acute
- Interventions
- OtoSight Middle Ear Scope
- Device
- Lead sponsor
- PhotoniCare, Inc.
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 700 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2026
- U.S. locations
- 7
- States / cities
- Washington D.C., District of Columbia • Miami, Florida • Orlando, Florida + 4 more
- Conditions
- Acute Otitis Media
- Interventions
- amoxicillin-clavulanate, Placebo
- Drug
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 6 Months to 23 Months
- Enrollment
- 291 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2009
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE, Prevention of Pneumococcal-induced Acute Otitis Media
- Interventions
- Inactivated whole-cell Streptococcus pneumoniae vaccine, Placebo
- Biological · Drug
- Lead sponsor
- Serum Life Science Europe GmbH
- Industry
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Acute Respiratory Tract Infection, Otitis Media, Pharyngitis, Acute Sinusitis
- Interventions
- Broad Implementation of Outpatient Stewardship (BIOS) intervention
- Behavioral
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 1,032 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2022 – 2025
- U.S. locations
- 5
- States / cities
- Plantation, Florida • Cleveland, Ohio • Hershey, Pennsylvania + 1 more
- Conditions
- Otitis Media Recurrent, Middle Ear Infection, Ear Infection
- Interventions
- Advanced Ultrasound Otoscope
- Device
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 0 Years to 12 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2027
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Acute Otitis Media
- Interventions
- Antipyrine and Benzocaine otic solution, Antipyrine Otic Solution, Benzocaine Otic Solution, Placebo Otic solution
- Drug
- Lead sponsor
- Currax Pharmaceuticals
- Industry
- Eligibility
- 2 Months to 12 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 10
- States / cities
- Mesa, Arizona • Tucson, Arizona • Bentonville, Arkansas + 5 more
- Conditions
- Acute Otitis Media
- Interventions
- Amoxicillin-Clavulanate potassium
- Drug
- Lead sponsor
- Nader Shaikh
- Other
- Eligibility
- 6 Months to 23 Months
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Acute Otitis Media
- Interventions
- cefdinir (Omnicef), azithromycin
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 6 Months to 6 Years
- Enrollment
- 357 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 30
- States / cities
- Columbiana, Alabama • Montgomery, Alabama • Ozark, Alabama + 24 more
- Conditions
- Acute Otitis Media
- Interventions
- cefdinir (Omnicef), amoxicillin
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 6 Months to 6 Years
- Enrollment
- 425 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Montgomery, Alabama • Ozark, Alabama + 28 more
- Conditions
- Acute Otitis Media, AOMT
- Interventions
- OTO-201
- Drug
- Lead sponsor
- Otonomy, Inc.
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 39 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 5
- States / cities
- Fresno, California • Fort Lauderdale, Florida • Charlotte, North Carolina + 2 more
- Conditions
- Acute Otitis Media
- Interventions
- Moxidex otic solution, Moxifloxacin otic solution, Vehicle, Tympanostomy tubes
- Drug · Other · Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 1
- States / cities
- Fort Worth, Texas
- Conditions
- Acute Otitis Media
- Interventions
- Acute Otitis Media Choice Decision Aid, Usual Care
- Other
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 6 Months to 18 Years
- Enrollment
- 101 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Acute Otitis Media, Acute Sinusitis, Group A Streptococcal Pharyngitis
- Interventions
- Broad-spectrum antibiotics, Narrow-spectrum antibiotics
- Drug
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 2,472 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Otitis Media With Effusion
- Interventions
- osteopathic manipulative medicine (OMM)
- Procedure
- Lead sponsor
- West Virginia School of Osteopathic Medicine
- Other
- Eligibility
- 6 Months to 2 Years
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 2
- States / cities
- Biddeford, Maine • Lewisburg, West Virginia
- Conditions
- Pain, Acute Otitis Media
- Interventions
- Benzocaine, Placebo
- Drug
- Lead sponsor
- Otic Therapy, LLC
- Industry
- Eligibility
- 2 Months to 12 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 3
- States / cities
- Clearwater, Florida • Gresham, Oregon • Murray, Utah
- Conditions
- Community Acquired Pneumonia (CAP), Sinusitis, Strep Pharyngitis, Acute Otitis Media (AOM)
- Interventions
- Online Educational Modules, Prescribing Feedback Reports, Clinical Decision Support, Live, hybrid in-person and online educational sessions
- Other
- Lead sponsor
- Children's Hospital of Philadelphia
- Other
- Eligibility
- 6 Months to 12 Years
- Enrollment
- 420 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Acute Otitis Media, Mastoiditis
- Interventions
- No intervention
- Other
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 0 Years and older
- Enrollment
- 391 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 8
- States / cities
- Little Rock, Arkansas • Los Angeles, California • San Diego, California + 5 more
- Conditions
- Acute Otitis Media, AOMT
- Interventions
- 6 mg ciprofloxacin, 12 mg ciprofloxacin, Sham
- Drug · Other
- Lead sponsor
- Otonomy, Inc.
- Industry
- Eligibility
- 6 Months to 17 Years
- Enrollment
- 95 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Otitis Media
- Interventions
- Zmax
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 3 Months to 48 Months
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006
- U.S. locations
- 2
- States / cities
- Bardstown, Kentucky • Springfield, Kentucky
- Conditions
- Acute Otitis Media (AOM)
- Interventions
- wSp vaccine, Saline (0.9% NaCl)
- Biological
- Lead sponsor
- Serum Life Science Europe GmbH
- Industry
- Eligibility
- 5 Months to 7 Months
- Enrollment
- 320 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 7
- States / cities
- Pittsford, New York • Rochester, New York
- Conditions
- Otitis Media
- Interventions
- Tympanocentesis, Nose/throat swab, Observational
- Procedure · Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 6 Months to 30 Months
- Enrollment
- 239 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 7
- States / cities
- Penfield, New York • Rochester, New York
- Conditions
- Otitis Media With Effusion, Acute Otitis Media
- Interventions
- tympanostomy tube
- Device
- Lead sponsor
- Integra LifeSciences Corporation
- Industry
- Eligibility
- 6 Months and older
- Enrollment
- 53 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 4
- States / cities
- Port Saint Lucie, Florida • Louisville, Kentucky • San Antonio, Texas + 1 more
- Conditions
- Acute Otitis Media (AOM), Strep Pharyngitis, Asthma Exacerbation, Pediatric Asthma
- Interventions
- Diagnostik home-based platform: multisensor device, software application, and artificial-intelligence algorithms that predict diagnosis of AOM and strep pharyngitis, Diagnostik home-based platform: multisensor device, software application, and artificial-intelligence algorithms that predict diagnosis of wheeze/asthma exacerbation, Routine Asthma Management (in-person and telehealth visits)- Control Group, Routine ENT Management (in-person and telehealth visits)- Control Group
- Device · Other
- Lead sponsor
- Medentum Innovations
- Industry
- Eligibility
- 3 Years to 17 Years
- Enrollment
- 84 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Tuscon, Arizona